Compounded tirzepatide injection technique: what TikTok gets right and wrong

What did @mixedwiththemosleys actually say?

Honestly, it's hard to know. The transcript from this video is largely incoherent, with phrases like "draw your maps," "borrow the pressure here," and "flip our code and shoot it down there." These appear to be heavily garbled captions of an actual injection demonstration, not a reliable verbal guide. The creator seems to be showing how to draw up and administer a compounded tirzepatide injection subcutaneously, but the audio-to-text rendering makes it nearly impossible to verify specific claims. What we can say is that the video positions itself as educational content about subcutaneous self-injection of a compounded GLP-1 medication.

This matters because 22,700 people watched this. If the verbal instruction is this unclear in transcript form, viewers may be piecing together injection technique from visual cues alone, which is a real patient safety concern when the medication in question requires precise dosing and sterile technique.

Does the science back this up?

Subcutaneous injection of tirzepatide is well-established in clinical practice, but the specifics matter enormously. The compounded version adds another layer of complexity that the video does not appear to address.

Tirzepatide, a dual GIP and GLP-1 receptor agonist, is FDA-approved as Mounjaro for type 2 diabetes and Zepbound for weight management. The branded versions come in prefilled auto-injectors with fixed doses. Compounded tirzepatide, by contrast, comes in vials requiring manual draw-up, which introduces variables including incorrect volume measurement, contamination risk, and dosing errors.

A 2023 study by Jastreboff et al. in the New England Journal of Medicine confirmed tirzepatide's efficacy and safety profile at doses titrated under medical supervision. The titration schedule exists specifically to reduce gastrointestinal adverse events. An informal injection tutorial that skips dose discussion and sterile field preparation is missing the clinical scaffolding that makes self-injection reasonably safe.

The CDC's injection safety guidelines are explicit: single-dose vials, proper site rotation, and sterile technique are non-negotiable. None of this appears addressed in what we can parse from the transcript.

What did they get wrong (or right)?

Without a clean transcript, we cannot credit or fault specific verbal claims. That ambiguity is itself a problem. Medical education content on TikTok carries weight whether creators intend it to or not, and viewers will fill in gaps with assumptions.

What is almost certainly missing from a tutorial like this: guidance on reconstitution if using lyophilized compounded tirzepatide, how to verify the correct dose in units on an insulin syringe versus milligrams of active drug, proper injection site selection and rotation, what to do if you see particulate matter or cloudiness, and when to contact your prescribing provider.

Compounded tirzepatide is not the same as Mounjaro or Zepbound. The FDA has flagged concerns about compounded GLP-1 medications specifically, issuing guidance in 2024 noting that compounded tirzepatide is not FDA-approved and that quality and potency can vary between compounding pharmacies. A video that treats it casually, with phrases like "shoot it down there," does not reflect that regulatory and clinical reality.

If the creator is a patient sharing their own experience, that context matters and deserves acknowledgment. But that framing is absent, and the hashtag "education" signals instructional intent.

What should you actually know?

If you are self-injecting compounded tirzepatide, the technique is genuinely important, and good tutorials do exist. Here is what a responsible one covers.

• Draw up your dose in a clean environment using the exact volume your provider prescribed. Confirm units versus milligrams with your pharmacy before your first injection.
• Inject subcutaneously into the abdomen, thigh, or upper arm. Rotate sites each week to avoid lipohypertrophy, a thickening of fat tissue that reduces drug absorption (Blanco et al., 2013, Diabetes Care).
• Use a new needle every time. Reusing needles dulls the tip, increases pain, and raises infection risk.
• Compounded medications may differ in concentration from branded versions. Never assume a volume that worked with one product is correct for another.
• If you experience severe nausea, vomiting, or abdominal pain after injection, contact your provider. These can signal too-rapid dose escalation or an adverse reaction.

Self-injection tutorials have real value for patients who lack hands-on clinical training. The problem is when they skip the parts that matter most, especially for a medication that requires careful titration and comes in a form that is not standardized across compounding pharmacies.